featured
Olanzapine Plus Standard Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Olanzapine 5 mg Plus Standard Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting (J-FORCE): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Oncol 2019 Dec 11;[EPub Ahead of Print], H Hashimoto, M Abe, O Tokuyama, H Mizutani, Y Uchitomi, T Yamaguchi, Y Hoshina, Y Sakata, TY Takahashi, K Nakashima, M Nakao, D Takei, S Zenda, K Mizukami, S Iwasa, M Sakurai, N Yamamoto, Y OheFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.